Evidence map›Paper›PMID 22522920›Full record

ArticleThe Laryngoscope2012

Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein.

Nathan S Alexander, Angela Blount, Shaoyan Zhang, Daniel Skinner, Stephen B Hicks, Michael Chestnut, Frederick A Kebbel, Eric J Sorscher, Bradford A Woodworth

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Laryngoscope, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  4. Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL).Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Observational
  5. Article
  6. Article
  7. Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Nasal Mucociliary Clearance in Smokers: A Systematic Review.International archives of otorhinolaryngology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Acquired cystic fibrosis transmembrane conductance regulator dysfunction.World journal of otorhinolaryngology - head and neck surgery · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nathan S AlexanderDepartment of Surgery/Division of Otolaryngology, Birmingham, Alabama, USA.
Angela Blount
Shaoyan Zhang
Daniel Skinner
Stephen B Hicks
Michael Chestnut
Frederick A Kebbel
Eric J Sorscher
Bradford A Woodworth
University of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMIT GAGGAR · 2007 to 2026
$23.0M
UAB Short-Term Research Training in Health Professional Schools (SHRT)T35HL007473 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAM M GEISLER · 1985 to 2026
$4.0M
Chloride secretagogues for acquired CFTR dysfunction in chronic rhinosinusitisK08HL107142 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WOODWORTH, BRADFORD ALAN · 2011 to 2015
$668k
NHLBI NIH HHS 1K08HL107142-01NHLBI NIH HHS K08 HL107142NHLBI NIH HHS T35 HL007473NIDDK NIH HHS 5P30DK072482-03NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

objectives/hypothesisEvidence indicates that decreased mucociliary clearance (MCC) is a major contributing feature to chronic rhinosinusitis. Tobacco-smoke exposure is thought to inhibit transepithelial Cl(-) secretion, a major determinant of airway surface liquid hydration and MCC. The objective of the current study was to evaluate the effects of acrolein exposure (a prominent tobacco smoke toxin) on vectorial Cl(-) transport through the major apical anion channel cystic fibrosis transmembrane conductance regulator (CFTR) in sinonasal epithelium. STUDY

designIn vitro investigation.

methodsPrimary murine nasal septal epithelia (MNSE; wild-type and transgenic CFTR(-/-)) cultures were exposed to acrolein in Ussing chambers and the effects on Cl(-) secretion investigated using pharmacologic manipulation. Cellular cyclic adenosine monophosphate (cAMP) signaling and cytotoxicity were also investigated.

resultsAcrolein stimulated Cl(-) secretion (ΔI(SC) - change in short-circuit current in μA/cm(2)) at concentrations similar to smoker's airways (100 μM, 15.8 ± 2.2 vs. 2.4 ± 0.8 [control]; P < .0001), suppressed forskolin-stimulated C- transport at 300 μM (13.3 ± 1.2 vs. 19.9 ± 1.0; P < .01), and completely abolished all transport at 500 μM (-1.1 ± 1.6). Stimulated Cl(-) secretion was solely reliant upon the presence of CFTR (confirmed in transgenic CFTR(-/-) MNSE), but independent of cAMP signaling. Inhibition at higher concentrations was not secondary to cellular cytotoxicity.

conclusionsThe present study demonstrates that acrolein has complex but pronounced interaction with the major apical Cl(-) transport mechanism that uses CFTR. Further investigations are required to determine acrolein's impact as a tobacco smoke constituent on mucociliary transport.

Indexed as

AcroleinAnalysis of VarianceAnimalsCells, CulturedCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorDose-Response Relationship, DrugEpithelial CellsIn Vitro TechniquesIon TransportMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMucociliary ClearanceNasal MucosaAcroleinCyclic AMPCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID22522920
PMCPMC3548450
OpenAlexW2004978232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.